H. B. Fuller Company
58.05-1.88 (-3.14%)
Oct 29, 4:00:02 PM EDT · NYSE · FUL · USD
Key Stats
Market Cap
3.14BP/E (TTM)
27.91Basic EPS (TTM)
2.08Dividend Yield
0.02%Recent Filings
8-K
Q3 revenue dips, margins expand
H.B. Fuller reported Q3 2025 net revenue of $892 million, down 2.8% year-over-year, yet adjusted EBITDA climbed 3% to $171 million with margins expanding 110 basis points to 19.1% on pricing gains and cost cuts. Adjusted EPS rose 12% to $1.26 amid softer volumes. Margins keep climbing. The company tightened full-year guidance, eyeing flat organic revenue and 4-5% adjusted EBITDA growth while bracing for economic headwinds.
10-Q
Q3 FY2025 results
H.B. Fuller posted Q3 FY2025 net revenue of $892M, down 2.8% y/y from $918M, with organic growth off 0.9% amid softer volumes yet pricing up 1.0%; gross margin climbed to 32.0% from 30.0%, fueled by higher prices and lower distribution costs. Operating income rose 5.6% y/y to $110M, while net income hit $67M, up 21.3% y/y, lifting diluted EPS to $1.22 from $0.98 on 55,162 diluted shares. Acquisitions like GEM and Medifill in January 2025 for ~$197M (cash/borrowings, $90M goodwill, $105M finite-lived intangibles over 10-15 years) bolstered medical adhesives, while the NA Flooring divestiture in December 2024 fetched $76M. Cash stood at $122M with $2.1B long-term debt (SOFR+1.75%, due 2030); free cash flow (derived) of $62M trailed last year's $104M. Engineering Adhesives shone with 17.2% margins. Regulatory pressures from CERCLA cleanups linger as a key risk.
8-K
Q2 results beat expectations
H.B. Fuller reported Q2 2025 net revenue of $898 million, down 2.1% year-over-year but up 2.8% adjusting for the flooring divestiture, while adjusted EBITDA climbed 5% to $166 million with margins expanding 130 basis points to 18.4% on cost savings and pricing. Adjusted EPS rose 5% to $1.18, fueled by higher net income and share repurchases. The company raised full-year guidance to $615–$630 million adjusted EBITDA and $4.10–$4.30 adjusted EPS. Net debt eased to 3.4x adjusted EBITDA.
10-Q
Q2 FY2025 net revenue of $898.1 million, down 2.1% y/y but up 0.4% organically excluding NA Flooring divestiture. Gross margin expanded to 31.9%, up 110 bps, driven by pricing and mix. Net income of $41.8 million, or $0.76 per diluted share, vs. $0.93 in Q2 FY2024. Adjusted EBITDA rose 18.7% to $91.9 million, with margin up 120 bps to 10.2%. Cash and equivalents stood at $96.8 million, with total debt at $2.11 billion.
H.B. Fuller Company reported Q2 FY2025 net revenue of $898.1 million, down 2.1% from $917.1 million in Q2 FY2024, with organic growth of 0.4% excluding the impact of the NA Flooring divestiture. Gross profit was $286.4 million, yielding a 31.9% margin, up 110 basis points from 30.8% in the prior year, driven by pricing and mix. Operating income reached $73.2 million, up 18.5%, with an operating margin of 8.1%, up 130 basis points. Net income attributable to H.B. Fuller was $41.8 million, or $0.76 per diluted share, compared to $51.3 million, or $0.93 per diluted share, in Q2 FY2024. Adjusted EBITDA was $91.9 million, up 18.7%, with an adjusted EBITDA margin of 10.2%, up 120 basis points. The company maintained a strong balance sheet with $96.8 million in cash and equivalents and $2.11 billion in total debt. H.B. Fuller continues to focus on growth priorities, including the integration of recent acquisitions and operational efficiencies.
8-K
Annual meeting results mixed
H.B. Fuller Company held its 2025 Annual Meeting on April 15, 2025, where shareholders elected Michael J. Happe, Charles T. Lauber, and Celeste B. Mastin to three-year board terms with strong support—over 93% votes for Lauber and Mastin, though Happe saw 3.3 million withheld. Ernst & Young LLP's appointment as auditors passed overwhelmingly with 51.1 million for votes. Executive compensation earned solid approval at 48.3 million for, but the amended 2020 Master Incentive Plan squeaked by with just 35.8 million for amid 13.9 million against. Shareholder input sharpens governance focus.
IPO
Website
Employees
Sector
Industry
CC
Chemours Company (The)
13.76-0.09
EMN
Eastman Chemical Company
61.08-2.28
FF
FutureFuel Corp.
3.93-0.16
HUN
Huntsman Corporation
8.68-0.37
MATV
Mativ Holdings, Inc.
10.89-0.13
NDEKF
Nitto Denko Corp.
25.40-0.09
PPG
PPG Industries, Inc.
99.13-6.18
RPM
RPM International Inc.
108.37-3.22
SHW
Sherwin-Williams Company (The)
345.73-8.72
SYHMY
Synthomer PLC
0.76+0.00